What is the new acute pain pill?: Journavx (Suzetrigine)
•
4 min read
In a major medical development, the FDA approved Journavx (suzetrigine) in January 2025, marking the first approval for a new class of pain medication in more than 20 years. This breakthrough offers a non-addictive option for treating moderate to severe acute pain, posing the question: What is the new acute pain pill?.
